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Cobelli, Claudio, Francesca Bettini, Andrea Caumo,
and Michael J. Quon. Overestimation of minimal model
glucose effectiveness in presence of insulin response is due to
undermodeling. Am. J. Physiol. 275 (Endocrinol. Metab. 38):
E1031–E1036, 1998.—Glucose effectiveness is an important
determinant of glucose tolerance that can be derived from
minimal model analysis of an intravenous glucose tolerance
test (IVGTT). However, recent evidence suggests that glucose
effectiveness is overestimated by minimal model analysis.
Here we compare a new model-independent estimate of
glucose effectiveness with the minimal model estimate by
reanalyzing published data in which insulin-dependent dia-
betic subjects were each given IVGTTs under two conditions
(Quon, M. J., C. Cochran, S. I. Taylor, and R. C. Eastman.
Diabetes 43: 890–896, 1994). In one case, a basal insulin level
was maintained (BI-IVGTT). In the second case, a dynamic
insulin response was recreated (DI-IVGTT). Our results show
that minimal model glucose effectiveness is very similar to
the model-independent measurement during a BI-IVGTT but
is three times higher during a DI-IVGTT. To investigate the
causes of minimal model overestimation in the presence of a
dynamic insulin response, Monte Carlo simulation studies on
a two-compartment model of glucose kinetics with various
insulin response patterns were performed. Results suggest
that minimal model overestimation is due to single-compart-
ment representation of glucose kinetics that results in a
critical oversimplification in the presence of increasingly
dynamic insulin secretion patterns.
intravenous glucose tolerance test; glucose kinetics
GLUCOSE EFFECTIVENESS, an important component of
glucose tolerance (1, 3), is defined as the ability of
glucose to promote its own disposal and inhibit its own
production in the absence of an incremental insulin
effect (i.e., when insulin is at basal levels) (2, 3).
An estimate of glucose effectiveness (SG) can be
obtained from the minimal model analysis of an intrave-
nous glucose tolerance test (IVGTT). However, both
indirect (6–8) and direct (10, 12) experimental evidence
indicates that SG is an overestimate of the true glucose
effectiveness and that SG estimation is influenced by
the insulin profile during the IVGTT.
The overestimation of SG has been suggested (7) to be
due, in large part, to the single-compartment approxi-
mation of glucose kinetics used by the minimal model.
Specifically, SG would incorporate a component reflect-
ing the exchange kinetics between the accessible and
the inaccessible pool of the glucose system. The relation-
ship between SG and a reference index of glucose
effectiveness has recently been investigated with model
simulation studies (9, 11, 13), but conflicting results
have been produced. Whereas in Refs. 9 and 13 no
correlation with the reference index was found, in Ref.
11 an excellent concordance was obtained. Evidence
has been provided (13), however, that the simulation
conducted in Ref. 11 poorly reflects real life (e.g., only
one parameter at a time is allowed to vary in the Monte
Carlo runs).
The sensitivity of SG to the insulin profile during the
IVGTT has not been well characterized, and many
issues remain open to question (5). Does overestimation
of SG occur only during an IVGTT when a dynamic
insulin response is elicited but not during an optimal
protocol (i.e., during an IVGTT when insulin is clamped
at its basal value)? If so, what is the cause? Another
issue that needs to be addressed is the following: if SG
depends on insulin dynamics during the IVGTT, what
is the role played by the insulin response during the
first 20 min of the test? This issue has practical
relevance because the insulin profile in the first 20 min
of the IVGTT is due exclusively to endogenous insulin
secretion and may differ considerably among groups,
whereas from 20 min on, the insulin profile is made
much more homogenous by exogenous insulin adminis-
tration.
In the present study we sought to address these
questions. To do so we relied on both experimental and
computer simulation studies. The data base consists of
a set of published data (12) in which subjects with
insulin-dependent diabetes mellitus (IDDM) were given
an IVGTT on one occasion with only basal insulin
provided (BI-IVGTT) and on a second occasion in the
presence of a dynamic insulin response (DI-IVGTT), in
which a normal insulin response was recreated through
a computer-controlled infusion of insulin. In our reanaly-
sis of this data, we first calculated from BI-IVGTT data
the model-independent reference measure of glucose
effectiveness, GE, recently proposed in Ref. 1. We next
used the minimal model to obtain estimates of SG from
both the BI-IVGTT and DI-IVGTT. Our results show
that SG derived from the BI-IVGTT is similar and very
well correlated to GE. In contrast, SG derived from the
DI-IVGTT is overestimated and correlates weakly with
GE. Finally, to investigate whether overestimation of
SG in the presence of an incremental insulin response
might be due to single-compartment undermodeling,
we used a two-compartment model of glucose kinetics
with various patterns of dynamic insulin responses to
generate computer simulation results. We show that
The costs of publication of this article were defrayed in part by the
payment of page charges. The article must therefore be hereby
marked ‘‘advertisement’’ in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
0193-1849/98 $5.00 Copyright r 1998 the American Physiological Society E1031
 o
n
 O
ctober 7, 2011
ajpendo.physiology.org
D
ow
nloaded from
 
the effect of insulin dynamics on SG is most likely a
consequence of undermodeling and that SG decreases
as insulin availability in the first 20 min of the test
decreases.
METHODS
The Data
The data we reanalyzed in this study were previously
published, and we refer to the original publication for all
details concerning subjects, experimental protocol, and as-
says (12). Briefly, seven subjects with IDDM, who had no
detectable endogenous insulin secretion, each underwent a
BI-IVGTT and a DI-IVGTT (0.3 g/kg). During the BI-IVGTT,
insulin was infused at a basal rate identical to that required
to keep the patient euglycemic during an overnight fast.
During the DI-IVGTT, a computer-controlled insulin infusion
was given in response to the intravenous glucose load to
mimic a normal insulin secretory response.
Glucose Effectiveness: Model-Independent Estimation
It has recently been shown (1) that glucose effectiveness
can be calculated under very general assumptions, i.e., virtu-
ally in a model-independent way, from an experiment in
which exogenous glucose is administered to produce a tran-
sient excursion of glucose above basal levels while insulin
remains at basal levels (e.g., BI-IVGTT). Under these condi-
tions, the assessment of glucose effectiveness does not require
any structural modeling of the glucose system and is simply
given by the ratio between the amount of exogenous glucose
administered and the area under the curve (AUC) of the
glycemic excursion above basal levels. It is worth remarking
that this AUC-based index of glucose effectiveness is also
equivalent, as shown in Ref. 1, to the analogous clamp-based
index. During a BI-IVGTT, glucose effectiveness (GE) is
GE 5
D
AUC[DG(t)]
(1)
where D is the glucose bolus dose, and AUC[DG] is the area
under the curve of the glucose concentration excursion above
basal (DG). It is worth noting that GE, which has the
dimension of a clearance rate, i.e., dl ·kg21 ·min21, measures
the effect of glucose not only to stimulate glucose utilization
but also to inhibit glucose production.
AUC[DG] can be evaluated with the trapezoidal rule or by
fitting a parametric function to the glucose data, e.g., a sum of
polynomials or exponentials, and deriving the AUC from the
estimated parameter values. The latter approach is statisti-
cally more robust, because it allows one to assess not only the
value of GE but also its precision. Because BI-IVGTT glucose
data DG are glucose decay data after a bolus injection, the
natural candidate to describe them is a sum of decaying
exponentials. We found that a two-exponential model was
necessary and sufficient, according to Akaike’s criterion (4), to
describe DG data
DG(t) 5 Ae2at 1 Be2bt (2)
Parameters A, a, B, and b were estimated by weighted
nonlinear least squares (4) with the assumption of a 2%
glucose measurement error and with weights chosen opti-
mally, i.e., equal to the inverse of the measurement error
variance. Precision of parameter estimates was obtained from
the inverse of the Fisher information matrix (4). By express-
ing AUC[DG] as a function of the two-exponential param-
eters, one has
GE 5
D
A
a
1
B
b
(3)
Precision of GE estimates can be obtained from the preci-
sion of A, a, B, and b estimates by error propagation (4).
Glucose Effectiveness: Minimal Model Estimation
Glucose effectiveness was estimated with the minimal
model of glucose disappearance (2) from both DI- and BI-
IVGTT data. As usually done in minimal model identification,
the first 10-min glucose samples were ignored to favor the
single-compartment approximation of glucose kinetics.
DI-IVGTT. During the DI-IVGTT, glucose disappearance
was described by the classical minimal model equations (2)
G˙(t) 5 2G(t)[SG 1 X(t)] 1 SGGb G(0) 5 Gb 1
D
V
X˙1t2 5 2p2 1 p33I1t2 2 Ib4 X102 5 0
(4)
where SG (min21) is glucose effectiveness, V is the minimal
model volume of glucose distribution (dl/kg), G is plasma
glucose concentration, I is plasma insulin concentration, X is
insulin action, p2 and p3 are rate parameters, and suffix b
denotes basal (end-test) values.
Parameters SG, V, p2, and p3 were estimated by weighted
nonlinear least squares (6) by assuming a 2% glucose measure-
ment error with weights chosen optimally. Precision of param-
eter estimates was obtained from the inverse of the Fisher
information matrix (4).
BI-IVGTT. During the BI-IVGTT, the above basal insulin
action X is identically null, and the model reduces to
G˙(t) 5 2SG[G(t) 2 Gb] G(0) 5 Gb 1
D
V
As a result, the model predicts that glucose decay is monoex-
ponential
G(t) 5
D
V
e2SGt 1 Gb
Parameters SG and V were estimated as described above.
Monte Carlo Simulation
To test the hypothesis that single-compartment undermod-
eling is responsible for the discrepancies between estimates of
glucose effectiveness obtained by model-independent and
minimal model analysis, we resorted to Monte Carlo simula-
tion such as in Refs. 9 and 13. The details of the Monte Carlo
simulation ingredients, e.g., model structure, parameter val-
ues, and noise level, are fully described in Ref. 13. Briefly, a
two-compartment model of glucose kinetics with endogenous
glucose production described by the same glucose-insulin
relationship embodied in the minimal model (2) was used as a
reference. Normal parameter values were chosen. Six differ-
ent insulin profiles (see Fig. 3 in RESULTS) were used as input
to the two-compartment model and, for each insulin profile,
200 noisy IVGTT glucose data sets were generated. In
addition to the standard (see Fig. 3A) and the basal insulin
IVGTT (see Fig. 3F), profiles from an insulin-modified IVGTT
showing a progressively decreasing first-phase insulin re-
sponse (from normal in Fig. 3C to no response in Fig. 3E) were
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also used. This allowed us to evaluate the sensitivity of the
minimal model glucose effectiveness to insulin dynamics in
the initial 20 min of the test. The generated plasma glucose
and insulin time courses were then used to estimate glucose
effectiveness with the minimal model (assuming known the
basal glucose and insulin concentrations and ignoring, as
usual, the first 10-min glucose samples).
Statistical Analysis
Data in the text and Figs. 1–3 are given as means 6 SE.
Linear regression analysis was used to evaluate the relation-
ship between GE and the minimal model assessment of
glucose effectiveness. The paired Student’s t-test was used to
compare different measures of glucose effectiveness made in
the same subject. P values ,0.05 were considered statisti-
cally significant.
RESULTS
Experimental Data
The time courses of plasma glucose (top) and insulin
(bottom) concentrations during the BI-IVGTT and DI-
IVGTT are shown in Fig. 1 (left and right, respectively).
During the BI-IVGTT, the insulin level was relatively
constant, and the glucose profile approached the base-
line ,6 h after the glucose injection. During the
DI-IVGTT, the glucose profile was similar to the one
that is commonly observed in subjects with normal
glucose tolerance.
Model-Independent GE
The two-exponential model fit was very good and is
shown in Fig. 2. The model-independent GE was calcu-
lated from precisely estimated parameters. For ex-
ample, a 5 0.205 6 0.022 min21, with a mean precision
of 17% (range 11–30%), and b 5 0.0040 6 0.0009 min21,
with a mean precision of 21% (range 3–24%). GE was
0.0099 6 0.0017 dl ·min21 ·kg21, with a mean precision
of 3% (Table 1).
Minimal Model Analysis of BI-IVGTT
and DI-IVGTT Data
The minimal model fit of BI-IVGTT data was as good
as that provided by the two-exponential model from 10
min on (Fig. 2). Parameters SG and V were estimated
with good precision. The mean values of SG and V were,
respectively, 0.0044 6 0.0007 (min21) and 2.76 6 0.25
Fig. 1. Plasma glucose (A and B) and
insulin (C and D) concentration time
courses in insulin-dependent diabetes
mellitus (IDDM) subjects (means 6 SE,
n 5 7) during intravenous glucose toler-
ance test (IVGTT) studies in which
basal insulin levels are maintained (BI-
IVGTT, left) or in which a dynamic,
incremental insulin response was recre-
ated through a computer-controlled in-
sulin infusion (DI-IVGTT, right).
Fig. 2. Two- (dashed line) and one-exponential (continuous line)
model fit to BI-IVGTT glucose data of Fig. 1. Values are means of
models fitted in each individual.
Table 1. Model-independent and minimal model
estimates of glucose effectiveness
Subject
No.
Model
Independent
GE, dl·
min21·kg21
Minimal Model SGV, dl·min21·kg21
DI-IVGTT BI-IVGTT
1 0.0135 (2)* 0.0333 (7) 0.0142 (2)
2 0.0052 (3) 0.0507 (9) 0.0073 (9)
3 0.0021 (2) 0.0381 (27) 0.0069 (10)
4 0.0097 (4) 0.0151 (23) 0.0099 (3)
5 0.0137 (3) 0.0215 (71) 0.0141 (2)
6 0.0119 (3) 0.0222 (63) 0.0121 (7)
7 0.0132 (2) 0.0248 (20) 0.0138 (3)
Mean
6SE 0.009960.0017 (3)† 0.029460.0050 (31) 0.011260.0012 (5)
GE and SGV, model-independent and minimal model measures,
respectively, of glucose effectiveness. BI-IVGTT and DI-IVGTT, intra-
venous glucose tolerance tests, respectively, in which a basal insulin
level was maintained or a dynamic insulin response was recreated.
Nos. in parentheses represent *individual or †mean precision of
parameter estimates expressed as percentages of the fractional SD.
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(dl/kg) with a mean precision of 5% (range 2–12%) and
2% (range 1–4%). Of note is that SG (0.0044 6 0.0007
min21) virtually coincided with the slowest component
b (0.0044 6 0.0009 min21) of the two-exponential model
and that there was an excellent correlation between
them (r 5 0.99, P , 0.001).
In the case of DI-IVGTT, the minimal model fit
assessed in terms of residuals was good, and all the
parameters SG, V, p2, and p3 were estimated with
satisfactory precision. In particular, the mean value of
SG was 0.0152 6 0.0029 min21, with a precision of 34%
(range 9–74%), and that of V was 2.01 6 0.17 dl/kg,
with a precision of 3% (range 2–5%).
Comparison Among Different Estimates
of Glucose Effectiveness
Estimates of glucose effectiveness derived from both
model-independent and minimal model analysis of this
data are shown in Table 1. Because SG measures
fractional glucose effectiveness (i.e., per unit of glucose
distribution volume), it was multiplied by V to obtain a
minimal-model measure of glucose effectiveness, SGV,
comparable with GE (1, 5). Precision of SGV was
obtained by error propagation. SGV estimated from
BI-IVGTT data (0.0112 6 0.0012 dl ·min21 ·kg21, mean
precision 5%) was virtually identical to GE. In addition,
SGV was highly correlated with GE (r 5 0.97, P ,
0.001), with the regression line not statistically differ-
ent from the identity line. In contrast, SGV from
DI-IVGTT data (0.0294 6 0.0050 dl ·min21 ·kg21) was
three times higher than GE, and the two measures
were poorly correlated (r 5 20.4).
The agreement between SGV derived from the BI-
IVGTT and GE was remarkable in each individual
except for subject no. 3, where SGV was three times
higher than GE. To ascertain if this discrepancy could
be due to the presence in this subject of a fast compo-
nent still playing an important role after 10 min, we
repeated the identification in all subjects by ignoring
the first 20-min glucose samples. SGV in subject no. 3
decreased from 0.0069 to 0.0033 min21, thus approach-
ing GE 5 0.0021 min21, whereas no appreciable modifi-
cations were noted in the other six subjects. As a result,
the mean value of SGV became 0.0105 6 0.0016 min21,
and the correlation with GE improved (r 5 0.999, P ,
0.000001).
Monte Carlo Simulation
The six insulin profiles used for the Monte Carlo
simulations to assess the effect of insulin dynamics on
SG estimation are shown in Fig. 3. The results are
reported in Table 2. They show that, when the minimal
model is used to interpret glucose data generated by a
more complex two-compartment model, SG estimation
is markedly influenced by insulin dynamics. Glucose
effectiveness was virtually the same with the standard
and the insulin-modified IVGTT, i.e., the DI-IVGTT
(profiles A and B) but markedly decreased with the
early insulin response (profiles C, D, and E). When
insulin remained at the basal level throughout the test
(profile F), as during the BI-IVGTT, the lowest value of
glucose effectiveness was obtained.
DISCUSSION
The IVGTT minimal model method provides, in
addition to an index of insulin sensitivity, an index of
glucose effectiveness that measures the ability of glu-
cose to favor its own disappearance from plasma by
promoting its own utilization and inhibiting its own
endogenous production when insulin is at basal levels.
This index has been shown to characterize several
pathophysiological states as well as to have predictive
power (see recent review in Ref. 3). However, recent
experimental evidence (10, 12) has shown that glucose
effectiveness estimated from a standard or an insulin-
modified IVGTT (when a dynamic incremental insulin
response is present) is overestimated when compared
with values derived from an IVGTT in which the
potentially confounding effect of hyperinsulinemia is
eliminated by maintaining insulin at its basal level
throughout the test. However, until recently it was
not possible to easily investigate the mechanism under-
lying this discrepancy, because a minimal model-
independent measure of glucose effectiveness was
needed to relate minimal model estimates to a refer-
ence measure.
In this study we have used the recently proposed
model-independent measure of glucose effectiveness (1)
to assess the domain of validity of the minimal model
measurement. Our results indicate that when the
minimal model index of glucose effectiveness (ex-
pressed as the product SGV) is estimated from an
IVGTT in which insulin is kept constant at the basal
level (BI-IVGTT), its results are virtually identical to
the glucose effectiveness index GE obtained in a model-
independent way from AUC calculations. In contrast,
when insulin changes dynamically (DI-IVGTT), the
minimal model overestimates the model-independent
measure of glucose effectiveness by a factor of three.
The excellent concordance between the minimal model
estimate of glucose effectiveness obtained from the
BI-IVGTT and GE is in contrast with the findings of
Finegood and Tzur (10), who reported no correlation
between the SG derived from the BI-IVGTT and SG(clamp),
i.e., the clamp-based index of glucose effectiveness. A
likely explanation of this discrepancy is related to the
fact that glucose effectiveness spans a relatively nar-
row range in many different metabolic states. This
makes the correlation analysis between different esti-
mates of glucose effectiveness extremely sensitive to
measurement errors and day-to-day variability. Note
that in this study SGV and GE have been calculated
from the same BI-IVGTT data, whereas in Ref. 10 the
SG and SG(clamp) were estimated with different experimen-
tal approaches on different days.
The concordance between SGV obtained from the
BI-IVGTT and GE indicates that the single-compart-
ment minimal model is adequate to measure glucose
effectiveness when insulin remains basal during the
E1034 MODEL-INDEPENDENT MEASURE OF GLUCOSE EFFECTIVENESS
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IVGTT. This occurs despite the fact that the minimal
model SGV hinges on a single-pool description of the
glucose system and is calculated by ignoring the first
10-min glucose samples, whereas GE is based on much
broader assumptions about the glucose system and is
calculated by relying on the whole glucose data set from
0 to 180 min. The reason why this happens is that,
during a BI-IVGTT, the fast component of glucose
disappearance, which is not accounted for by the mini-
mal model, quickly fades away (within the initial 20
min of the test). From that time on, glucose decay is
well described by the slow component only. This can
easily be seen by referring to the parameters of the
two-exponential function used to calculate AUC[DG], as
in Eq. 3. Because A/a ,, B/b (see RESULTS), for the
calculation of AUC[DG], and thus of GE, the (slowest)
exponential function is enough, or, in other terms, the
contribution to AUC[DG] of the fast exponential is
negligible. Now, if one sees the minimal model in its
exponential version (Eq. 6), it is clear why the model-
independent GE and the minimal model SGV give the
same results. Note that this reasoning would have been
much less transparent if the trapezoidal method had
been used to calculate AUC[DG], and thus GE. One
additional observation is that the equivalence between
SGV and GE, which holds for a BI-IVGTT, cannot be
taken for granted in other experimental conditions,
even when insulin is maintained at the basal level. In
fact, there may be cases in which, due to a format of
glucose administration with relatively rapid and fre-
Fig. 3. Insulin profiles used in Monte
Carlo simulation. Insulin profiles A and
B are typical of a standard and an
insulin-modified IVGTT, respectively.
Profiles C, D, and E are from an insulin-
modified IVGTT showing progressively
decreasing first-phase insulin response.
Profile F comes from an IVGTT in which
insulin is maintained at the basal level
throughout the study.
Table 2. Minimal model glucose effectiveness with
different insulin profiles
Insulin
Profile
SG
min21
V
dl/kg
SGV
dl ·min21 ·kg21
A 0.023 2.0 0.046
B 0.024 1.9 0.045
C 0.020 2.0 0.040
D 0.017 2.1 0.035
E 0.014 2.2 0.031
F 0.009 2.5 0.023
SG, minimal model fractional glucose effectiveness in DI-IVGTT; V,
minimal model volume of glucose distribution; SGV, minimal model
glucose effectiveness.
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quent changes, the behavior of the glucose system cannot
be well approximated by a single-compartment model.
Our result, that the minimal model glucose effective-
ness obtained from a DI-IVGTT is three times higher
than that estimated from a BI-IVGTT, is clearly a
symptom of model error. The sensitivity of SG to the
IVGTT insulin profile has also recently been observed
in dog studies by Finegood and Tzur (10), but no
mechanistic explanation of why this happens was
offered in that study. In the present study, we resorted
to Monte Carlo simulation to clarify whether single-
compartment undermodeling can explain SG sensitivity
to insulin dynamics. A physiologically based two-
compartment model was used to simulate IVGTT glu-
cose data in the presence of different insulin profiles.
We reasoned that, if undermodeling plays a role in
making SG sensitive to insulin dynamics during the
IVGTT, the minimal model SG estimated from simu-
lated BI-IVGTT and DI-IVGTT data should exhibit the
same trend observed with real data. As a matter of fact,
similarly to Finegood and Tzur (10) and to the experi-
mental results obtained in the present study, SG esti-
mated from a simulated DI-IVGTT (Fig. 3, profiles A
and B) was higher than that estimated from a simu-
lated BI-IVGTT (profile F). Moreover, SG progressively
decreased with the early insulin response (Fig. 3,
profiles C, D, and E), thus corroborating the suggestion
of Finegood and Tzur that caution must be exercised in
the interpretation of differences in the estimates of SG
between subject groups with significant differences in
b-cell function. Of note is that the value of SGV esti-
mated from simulated BI-IVGTT (profile F) was close to
the glucose effectiveness of the reference two-compart-
ment model (0.0023 vs. 0.0021 dl ·min21 ·kg21). This
result obtained from simulated data confirms that the
minimal model yields an accurate estimate of glucose
effectiveness only when insulin remains at the basal level
during the IVGTT.
All in all, the experimental results of this study, those
of Finegood and Tzur (10), and our Monte Carlo simula-
tions suggest that the single-pool description is reason-
ably adequate when the glucose system is studied at
basal insulin but becomes critical when insulin is
elevated in the initial portion of the IVGTT. A possible
explanation is related to the fact that, at variance with
the BI-IVGTT when glucose decay is dictated by glu-
cose effectiveness only, during a DI-IVGTT the minimal
model has to distinguish between the individual contri-
butions of glucose and insulin action to glucose disap-
pearance. During a DI-IVGTT, SG is mainly estimated
in the initial portion of the test, when glucose concentra-
tion is high and insulin action, albeit increasing, is still
low. As a result, SG assumes a value that reflects both
the fast and slow components of glucose disappearance
per se. The value taken on by SG progressively de-
creases with the early insulin response, because the
portion of the IVGTT crucial for its estimation (i.e.,
when glucose is high and insulin action is low) becomes
wider and wider. As a consequence, SG reflects a
combination of the two components in which the role
played by the fast component becomes less and less
important. In particular, during a BI-IVGTT, SG gets
close to the slow component because SG is estimated
from the entire 180-min glucose data set.
In conclusion, the results of the present study show
that the minimal model estimate of glucose effective-
ness is very similar to a model-independent measure-
ment when insulin is kept at basal level, but not when
it exhibits the dynamic pattern traditionally observed
during an IVGTT. Monte Carlo simulation results
suggest that single-compartment undermodeling can
explain SG sensitivity to insulin dynamics and that the
early insulin response during the IVGTT markedly
influences the value assumed by SG.
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